140 related articles for article (PubMed ID: 2838291)
1. Teniposide (VM26): an effective treatment for brain metastases of small cell carcinoma of the lung.
Giaccone G; Donadio M; Bonardi GM; Testore F; Calciati A
Eur J Cancer Clin Oncol; 1988 Apr; 24(4):629-31. PubMed ID: 2838291
[TBL] [Abstract][Full Text] [Related]
2. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
[TBL] [Abstract][Full Text] [Related]
3. Teniposide in the treatment of small-cell lung cancer: the influence of prior chemotherapy.
Giaccone G; Donadio M; Bonardi G; Testore F; Calciati A
J Clin Oncol; 1988 Aug; 6(8):1264-70. PubMed ID: 2842464
[TBL] [Abstract][Full Text] [Related]
4. Treatment of brain metastases of small cell lung cancer with teniposide.
Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
[TBL] [Abstract][Full Text] [Related]
5. VM26 (NSC-122819): a clinical study in advanced cancer of the lung and ovary.
Samson MK; Baker LH; Talley RW; Fraile RJ
Eur J Cancer (1965); 1978 Dec; 14(12):1395-9. PubMed ID: 216556
[No Abstract] [Full Text] [Related]
6. Teniposide (VM26) as second-line treatment for small cell lung cancer.
Tummarello D; Guidi F; Torresi U; Dazzi C; Cellerino R
Anticancer Res; 1990; 10(2A):397-9. PubMed ID: 2161198
[TBL] [Abstract][Full Text] [Related]
7. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
[TBL] [Abstract][Full Text] [Related]
8. Podophyllotoxins for brain metastases of small cell lung cancer.
Haaxma-Reiche H; Berendsen HH; Postmus PE
J Neurooncol; 1988 Nov; 6(3):231-2. PubMed ID: 2852221
[TBL] [Abstract][Full Text] [Related]
9. A case of small cell lung cancer successfully treated with VM26.
Suga J; Saijo N; Shinkai T; Eguchi K; Sasaki Y; Sakurai M; Sano T; Tamura T; Morinaga S
Jpn J Clin Oncol; 1986 Jun; 16(2):123-8. PubMed ID: 3016377
[TBL] [Abstract][Full Text] [Related]
10. Treatment of brain metastases of small-cell lung cancer: comparing teniposide and teniposide with whole-brain radiotherapy--a phase III study of the European Organization for the Research and Treatment of Cancer Lung Cancer Cooperative Group.
Postmus PE; Haaxma-Reiche H; Smit EF; Groen HJ; Karnicka H; Lewinski T; van Meerbeeck J; Clerico M; Gregor A; Curran D; Sahmoud T; Kirkpatrick A; Giaccone G
J Clin Oncol; 2000 Oct; 18(19):3400-8. PubMed ID: 11013281
[TBL] [Abstract][Full Text] [Related]
11. A phase II study with teniposide (VM26) in patients with progressed or relapsed small cell lung cancer (SCLC).
Tummarello D; Guidi F; Di Furia L; Gramazio A; Menichetti E; Cellerino R
J Chemother; 1989 Feb; 1(1):64-7. PubMed ID: 2542470
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of teniposide in small cell carcinoma of the lung.
Pedersen AG; Bork E; Osterlind K; Dombernowsky P; Hansen HH
Cancer Treat Rep; 1984 Oct; 68(10):1289-91. PubMed ID: 6098366
[TBL] [Abstract][Full Text] [Related]
13. Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).
Cerny T; Pedrazzini A; Joss RA; Brunner KW
Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1791-4. PubMed ID: 2850194
[TBL] [Abstract][Full Text] [Related]
14. Teniposide in the treatment of non-small cell lung carcinoma.
Giaccone G; Donadio M; Ferrati P; Bonardi G; Ciuffreda L; Bagatella M; Calciati A
Cancer Treat Rep; 1987 Jan; 71(1):83-5. PubMed ID: 3024829
[TBL] [Abstract][Full Text] [Related]
15. Phase II study of teniposide in advanced breast cancer.
Boas J; Rasmussen D; Hansen OP; Engelholm SA; Dombernowsky P
Cancer Chemother Pharmacol; 1990; 25(6):463-4. PubMed ID: 2311176
[TBL] [Abstract][Full Text] [Related]
16. Factors influencing response to second-line treatment with teniposide (VM26) in patients with progressive small cell lung cancer (SCLC).
Tummarello D; Graziano F; Giordani P; Cellerino R
Anticancer Res; 1993; 13(4):1055-8. PubMed ID: 8394668
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic trials with VP-16-213 and VM-26: active agents in small cell lung cancer, non-Hodgkin's lymphomas, and other malignancies.
Radice PA; Bunn PA; Ihde DC
Cancer Treat Rep; 1979 Aug; 63(8):1231-9. PubMed ID: 225026
[No Abstract] [Full Text] [Related]
18. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
[TBL] [Abstract][Full Text] [Related]
19. In vitro antitumor activity of teniposide against carcinoma of the lung in human tumor clonogenic assay.
Matsushima Y; Kanzawa F; Miyazawa N; Sasaki Y; Saijo N
Anticancer Res; 1986; 6(5):921-4. PubMed ID: 3026235
[TBL] [Abstract][Full Text] [Related]
20. Teniposide (VM-26), an overlooked highly active agent in small-cell lung cancer. Results of a phase II trial in untreated patients.
Bork E; Hansen M; Dombernowsky P; Hansen SW; Pedersen AG; Hansen HH
J Clin Oncol; 1986 Apr; 4(4):524-7. PubMed ID: 3007684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
